Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Mocellin

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Current Medicinal Chemistry|July 1, 2010
Targeting death receptors to fight cancer: from biological rational to clinical implementationS Mocellin
Current Medicinal Chemistry|August 18, 2010
The anticancer face of interferon alpha (IFN-alpha): from biology to clinical results, with a focus on melanomaS Pasquali, S Mocellin
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 21, 2013
Gastrointestinal carcinoid: epidemiological and survival evidence from a large population-based study (n = 25 531)S Mocellin, D Nitti
Current Medicinal Chemistry|November 26, 2009
Peptide-based anticancer vaccines: recent advances and future perspectivesS Mocellin, P Pilati, D Nitti
Current Medicinal Chemistry|July 14, 2012
Cancer resistance to type II topoisomerase inhibitorsP Pilati, D Nitti, S Mocellin
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 7, 2001
Cytokines and immune response in the tumor microenvironmentS Mocellin, E Wang, F M Marincola
Current Medicinal Chemistry|July 14, 2012
Circumventing melanoma chemoresistance by targeting DNA repairS Mocellin, L Bertazza, C Benna, et al.
International Journal of Cancer|June 19, 2001
Kinetics of cytokine expression in melanoma metastases classifies immune responsivenessS Mocellin, G A Ohnmacht, E Wang, et al.
Minerva Chirurgica|October 28, 2009
[Adjuvant chemotherapy after radical liver resection in the treatment of metastases from colorectal carcinoma]E Mammano, P Pilati, E Tessari, et al.
Histology and Histopathology|March 22, 2003
Use of laser scanning cytometry to study tumor microenvironmentS Mocellin, E Wang, M Panelli, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Current Medicinal Chemistry|July 1, 2010
Targeting death receptors to fight cancer: from biological rational to clinical implementationS Mocellin
Current Medicinal Chemistry|August 18, 2010
The anticancer face of interferon alpha (IFN-alpha): from biology to clinical results, with a focus on melanomaS Pasquali, S Mocellin
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 21, 2013
Gastrointestinal carcinoid: epidemiological and survival evidence from a large population-based study (n = 25 531)S Mocellin, D Nitti
Current Medicinal Chemistry|November 26, 2009
Peptide-based anticancer vaccines: recent advances and future perspectivesS Mocellin, P Pilati, D Nitti
Current Medicinal Chemistry|July 14, 2012
Cancer resistance to type II topoisomerase inhibitorsP Pilati, D Nitti, S Mocellin
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 7, 2001
Cytokines and immune response in the tumor microenvironmentS Mocellin, E Wang, F M Marincola
Current Medicinal Chemistry|July 14, 2012
Circumventing melanoma chemoresistance by targeting DNA repairS Mocellin, L Bertazza, C Benna, et al.
International Journal of Cancer|June 19, 2001
Kinetics of cytokine expression in melanoma metastases classifies immune responsivenessS Mocellin, G A Ohnmacht, E Wang, et al.
Minerva Chirurgica|October 28, 2009
[Adjuvant chemotherapy after radical liver resection in the treatment of metastases from colorectal carcinoma]E Mammano, P Pilati, E Tessari, et al.
Histology and Histopathology|March 22, 2003
Use of laser scanning cytometry to study tumor microenvironmentS Mocellin, E Wang, M Panelli, et al.
Pageof 5